Donatussin - 16477-185-01 - (Chlophedianol Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride)

Alphabetical Index


Drug Information of Donatussin

Product NDC: 16477-185
Proprietary Name: Donatussin
Non Proprietary Name: Chlophedianol Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride
Active Ingredient(s): 12.5; 120; 5    mg/5mL; mg/5mL; mg/5mL & nbsp;   Chlophedianol Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): SYRUP
Coding System: National Drug Codes(NDC)

Labeler Information of Donatussin

Product NDC: 16477-185
Labeler Name: Laser Pharmaceuticals, LLC
Product Type: HUMAN OTC DRUG
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20110928

Package Information of Donatussin

Package NDC: 16477-185-01
Package Description: 473 mL in 1 BOTTLE (16477-185-01)

NDC Information of Donatussin

NDC Code 16477-185-01
Proprietary Name Donatussin
Package Description 473 mL in 1 BOTTLE (16477-185-01)
Product NDC 16477-185
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Chlophedianol Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride
Dosage Form Name SYRUP
Route Name ORAL
Start Marketing Date 20110928
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Laser Pharmaceuticals, LLC
Substance Name CHLOPHEDIANOL HYDROCHLORIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Strength Number 12.5; 120; 5
Strength Unit mg/5mL; mg/5mL; mg/5mL
Pharmaceutical Classes

Complete Information of Donatussin


General Information